Xu Lei, Huang Xin, Lou Yan, Xie Wei, Zhao Hangyu
Department of Orthopedics, Chengdu Seventh People's Hospital, Chengdu, Sichuan 610213, P.R. China.
Department of Orthopedic Oncology, Spine Tumor Center, Changzheng Hospital, Naval Military Medical University, Shanghai 200003, P.R. China.
Exp Ther Med. 2022 May;23(5):352. doi: 10.3892/etm.2022.11279. Epub 2022 Mar 28.
Non-small cell lung cancer (NSCLC), a common type of cancer worldwide, is normally associated with a poor prognosis. It is difficult to treat successfully as it often metastasizes into brain or bone. Methods to facilitate the induction of effective programmed cell death (PCD) in NSCLC cells to reverse drug resistance, or to inhibit the invasion and migration of NSCLC cells, are currently under investigation. The present study summarized the regulatory functions of PCD, including apoptosis, autophagy and ferroptosis, in the context of NSCLC metastasis. It further summarized how regulatory agents, including long non-coding RNAs, circular RNAs and microRNAs, regulate PCD during the metastasis of NSCLC and characterized new potential diagnostic biomarkers of NSCLC metastasis.
非小细胞肺癌(NSCLC)是全球常见的癌症类型,通常预后较差。由于它经常转移至脑或骨,所以难以成功治疗。目前正在研究促进NSCLC细胞中有效程序性细胞死亡(PCD)诱导以逆转耐药性,或抑制NSCLC细胞侵袭和迁移的方法。本研究总结了PCD(包括凋亡、自噬和铁死亡)在NSCLC转移中的调控功能。它还进一步总结了包括长链非编码RNA、环状RNA和微小RNA在内的调控因子在NSCLC转移过程中如何调节PCD,并鉴定了NSCLC转移的新的潜在诊断生物标志物。